Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-04-15

Clinical Trial Update: Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial of directly administered antiretroviral therapy for HIV-1 infected injecting drug users in Chennai, India has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Johns Hopkins University | Conditions: HIV Infections, Heroin Dependence | Phase 2, Phase 3 | Status: WITHDRAWN